Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma

被引:16
|
作者
Fleming, S. [1 ]
Cooper, R. A. [2 ]
Swift, S. E. [1 ]
Thygesen, H. H. [3 ]
Chowdhury, F. U. [1 ,4 ]
Scarsbrook, A. F. [1 ,4 ]
Patel, C. N. [1 ,4 ]
机构
[1] St James Univ Hosp, Dept Clin Radiol, Leeds LS9 7TF, W Yorkshire, England
[2] St James Univ Hosp, Dept Clin Oncol, Leeds LS9 7TF, W Yorkshire, England
[3] St James Univ Hosp, Leeds Canc Res UK Ctr, Leeds LS9 7TF, W Yorkshire, England
[4] St James Univ Hosp, Dept Nucl Med, Leeds LS9 7TF, W Yorkshire, England
关键词
POSITRON-EMISSION-TOMOGRAPHY; CANCER PATIENTS; CHEMORADIOTHERAPY; RADIOTHERAPY; SURVIVAL; PATTERNS; FAILURE;
D O I
10.1016/j.crad.2014.07.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To evaluate the impact of staging FDG PET-CT on the initial management of patients with locally advanced cervical carcinoma (LACC) and any prognostic variables predicting survival. MATERIALS AND METHODS: Retrospective analysis of consecutive patients undergoing FDG PET-CT for staging of LACC in a single tertiary referral centre, between April 2008 and August 2011. Comparison was made between MRI and PET-CT findings and any subsequent impact on treatment intent or radiotherapy planning was evaluated. RESULTS: Sixty-three patients underwent FDG PET-CT for initial staging of LACC. Major impact on management was found in 20 patients (32%), a minor impact in five (8%), and no impact in 38 (60%). In those patients where PET-CT had a major impact, 12 had more extensive local nodal involvement, five had occult metastatic disease, two had synchronous tumours, and one patient had equivocal lymph nodes on MRI characterized as negative. PET-positive nodal status at diagnosis was found to be a statistically significant predictor of relapse-free survival (p < 0.05). CONCLUSION: Staging FDG PET-CT has a major impact on the initial management of approximately one-third of patients with LACC by altering treatment intent and/or radiotherapy planning. PET-defined nodal status is a poor prognostic indicator. (C) 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1235 / 1243
页数:9
相关论文
共 50 条
  • [21] Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer
    Arias, F.
    Chicata, V.
    Garcia-Velloso, M. J.
    Asin, G.
    Uzcanga, M.
    Eito, C.
    Quilez, I.
    Viudez, A.
    Saenz, J.
    Hernandez, I.
    Caicedo, C.
    Errasti, M.
    Barrado, M.
    Garcia-Bragado, F.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (02): : 139 - 144
  • [22] Impact of initial FDG PET/CT in the management plan of patients with locally advanced head and neck cancer
    F. Arias
    V. Chicata
    M. J. García-Velloso
    G. Asín
    M. Uzcanga
    C. Eito
    I. Quilez
    A. Viudez
    J. Saenz
    I. Hernández
    C. Caicedo
    M. Errasti
    M. Barrado
    F. García-Bragado
    Clinical and Translational Oncology, 2015, 17 : 139 - 144
  • [23] Unknown Primary Tumours in Patients with Verified Cervical Lymph Node Metastases: The Clinical Impact of FDG PET-CT
    Fulop, M.
    Kasler, M.
    Remenar, E.
    Lengyel, Z.
    Borbely, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S558 - S559
  • [24] F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma
    Cetina, Lucely
    Serrano, Alberto
    Cantu-de-Leon, David
    Perez-Montiel, Delia
    Estrada, Enrique
    Coronel, Jaime
    Hernandez-Lucio, Martha
    Duenas-Gonzalez, Alfonso
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (03): : 227 - 235
  • [25] Prognostic role of early FDG-PET/CT in locally advanced cervical carcinoma patients (LACC): preliminary results
    Di Paolo, A.
    Carideo, L.
    Saccomanno, A.
    Anzellini, D.
    De Sanctis, V.
    Pizzichini, P.
    Lanzolla, T.
    Capriotti, G.
    Signore, A.
    Prosperi, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S550 - S550
  • [26] Impact of FDG PET-CT in the staging and management of follicular lymphoma
    Metser, Ur
    Hussey, Douglas
    Murphy, Grainne
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [27] Has FDG PET/CT an impact on the management of patients with anal carcinoma?
    Vercellino, L.
    de Parades, V.
    Nataf, V.
    Kerrou, K.
    Huchet, V.
    Bauer, P.
    Pascal, O.
    Touboul, E.
    Montravers, F.
    Talbot, J. -N.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (02): : 96 - 102
  • [28] Initial Staging of Locally Advanced Cervical Cancer with FDG-PET/CT
    Caresia Aroztegui, A.
    Barahona Orpinell, M.
    Gamez Cenzano, C.
    Rodriguez Bel, L.
    Cortes Romera, M.
    Ponce Sebastia, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S472 - S472
  • [29] Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer
    Briggs, R. H.
    Chowdhury, F. U.
    Lodge, J. P. A.
    Scarsbrook, A. F.
    CLINICAL RADIOLOGY, 2011, 66 (12) : 1167 - 1174
  • [30] Value of FDG-PET/CT for staging of locally advanced cervical cancer
    Barahona, Marc
    Marti, Lola
    Perlaza-Jimenez, Pilar
    Fernandez-Gonzalez, Sergi
    Torrejon, Juan Carlos
    Castilla, Mireia
    Vidal, August
    Najjari-Namal, Dina
    Stefanovic, Milica
    Pardo, Beatriz
    Gil-Martin, Marta
    Ponce, Jordi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A8 - A9